Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine

We examined the acute effect of the irreversible GABA‐transaminase inhibitor, gamma‐vinyl GABA (GVG, Sabril®, Vigabatrin®) on increases in nucleus accumbens (NAc) dopamine (DA) following acute administration of methamphetamine, heroin, or ethanol. Methamphetamine (2.5 mg/kg) produced a dose‐dependen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Synapse (New York, N.Y.) N.Y.), 1999-10, Vol.34 (1), p.11-19
Hauptverfasser: Gerasimov, Madina R., Ashby Jr, Charles R., Gardner, Eliot L., Mills, Mark J., Brodie, Jonathan D., Dewey, Stephen L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 19
container_issue 1
container_start_page 11
container_title Synapse (New York, N.Y.)
container_volume 34
creator Gerasimov, Madina R.
Ashby Jr, Charles R.
Gardner, Eliot L.
Mills, Mark J.
Brodie, Jonathan D.
Dewey, Stephen L.
description We examined the acute effect of the irreversible GABA‐transaminase inhibitor, gamma‐vinyl GABA (GVG, Sabril®, Vigabatrin®) on increases in nucleus accumbens (NAc) dopamine (DA) following acute administration of methamphetamine, heroin, or ethanol. Methamphetamine (2.5 mg/kg) produced a dose‐dependent increase (2,700%) in NAc DA. GVG preadministration (300 or 600 mg/kg), however, inhibited this response by approximately 39 and 61%, respectively. The lower dose of methamphetamine (1.25 mg/kg), increased DA by 1,700%. This response was inhibited to a similar extent (44%) regardless of the GVG dose preadministered (300 or 600 mg/kg). In addition, heroin‐induced increases in NAc DA (0.5 mg/kg, 170%) were inhibited or completely abolished by GVG (150 or 300 mg/kg, 65 and 100%, respectively). Finally, at half the dose necessary for heroin, GVG (150 mg/kg) also completely abolished ethanol‐induced increases in NAc DA following a 0.25 g/kg challenge dose (140%). Taken with our previous findings using nicotine or cocaine as the challenge drug, these results indicate that GVG attenuates increases in NAc DA by a mechanism common to many drugs of abuse. However, it appears unlikely that an acute dose of GVG can completely inhibit increases in NAc DA following challenges with a drug whose mechanism of action is mediated primarily through the DA reuptake site. Synapse 34:11–19, 1999. © 1999 Wiley‐Liss, Inc.
doi_str_mv 10.1002/(SICI)1098-2396(199910)34:1<11::AID-SYN2>3.0.CO;2-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69993833</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17509396</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4282-9348286d94f0bd2b22c7ac3a9c46c52811df7e0437b54da5d44e1e86ccd123db3</originalsourceid><addsrcrecordid>eNqFkV9v0zAUxS0EYmXwFVCe0CYtxdd2_rhDSCWwUmlakQoCnq4c21XN4qTEDdBvT7JMAwkEL762fO7vSOcQcg50CpSy5yfrZbE8BSrzmHGZnoCUEugpFzN4ATCbzZev4_XnK_aST-m0WJ2zOLlHJnf6-2RC8zyLhcjSI_IohC-UUg5UPCRH_ZlISLMJ8QvlvYq_ufpQRYv5q3nk6q0r3T5E3u63yu-2dq-8q-1ZtLVt4-qzqGmj4atuqtjVptPW9Eu6tSrY0N-iutOV7UKktO58aesQmWZ3w3hMHmxUFeyT23lMPly8eV-8jS9Xi2Uxv4y1YDmLJRc5y1MjxYaWhpWM6UxprqQWqU5YDmA2maWCZ2UijEqMEBZsnmptgHFT8mPybOTu2uZrZ8MevQvaVpWqbdMFTPsoec75f4WQJVT2YfbC9SjUbRNCaze4a51X7QGB4lAX4lAXDvHjED-OdSEXCAiA2NeFQ13IkWKxQoZJT316a9-V3prfmGM_v2y_u8oe_vD8t-VfHG_ePTUeqS7s7Y87qmqvsffMEvx4tcBPUAC_eLfGgv8Ej9y_Fw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17509396</pqid></control><display><type>article</type><title>Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Gerasimov, Madina R. ; Ashby Jr, Charles R. ; Gardner, Eliot L. ; Mills, Mark J. ; Brodie, Jonathan D. ; Dewey, Stephen L.</creator><creatorcontrib>Gerasimov, Madina R. ; Ashby Jr, Charles R. ; Gardner, Eliot L. ; Mills, Mark J. ; Brodie, Jonathan D. ; Dewey, Stephen L.</creatorcontrib><description>We examined the acute effect of the irreversible GABA‐transaminase inhibitor, gamma‐vinyl GABA (GVG, Sabril®, Vigabatrin®) on increases in nucleus accumbens (NAc) dopamine (DA) following acute administration of methamphetamine, heroin, or ethanol. Methamphetamine (2.5 mg/kg) produced a dose‐dependent increase (2,700%) in NAc DA. GVG preadministration (300 or 600 mg/kg), however, inhibited this response by approximately 39 and 61%, respectively. The lower dose of methamphetamine (1.25 mg/kg), increased DA by 1,700%. This response was inhibited to a similar extent (44%) regardless of the GVG dose preadministered (300 or 600 mg/kg). In addition, heroin‐induced increases in NAc DA (0.5 mg/kg, 170%) were inhibited or completely abolished by GVG (150 or 300 mg/kg, 65 and 100%, respectively). Finally, at half the dose necessary for heroin, GVG (150 mg/kg) also completely abolished ethanol‐induced increases in NAc DA following a 0.25 g/kg challenge dose (140%). Taken with our previous findings using nicotine or cocaine as the challenge drug, these results indicate that GVG attenuates increases in NAc DA by a mechanism common to many drugs of abuse. However, it appears unlikely that an acute dose of GVG can completely inhibit increases in NAc DA following challenges with a drug whose mechanism of action is mediated primarily through the DA reuptake site. Synapse 34:11–19, 1999. © 1999 Wiley‐Liss, Inc.</description><identifier>ISSN: 0887-4476</identifier><identifier>EISSN: 1098-2396</identifier><identifier>DOI: 10.1002/(SICI)1098-2396(199910)34:1&lt;11::AID-SYN2&gt;3.0.CO;2-5</identifier><identifier>PMID: 10459167</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject><![CDATA[addiction ; Analgesics, Opioid - antagonists & inhibitors ; Analgesics, Opioid - pharmacology ; Animals ; Anticonvulsants - pharmacology ; Central Nervous System Depressants - antagonists & inhibitors ; Central Nervous System Depressants - pharmacology ; dopamine ; Dopamine - cerebrospinal fluid ; Dopamine - metabolism ; Dopamine Uptake Inhibitors - antagonists & inhibitors ; Dopamine Uptake Inhibitors - pharmacology ; ethanol ; Ethanol - antagonists & inhibitors ; Ethanol - pharmacology ; Extracellular Space - metabolism ; g-vinyl ^g-aminobutyric acid ; gamma vinyl-GABA ; gamma-Aminobutyric Acid - analogs & derivatives ; gamma-Aminobutyric Acid - pharmacology ; heroin ; Heroin - antagonists & inhibitors ; Heroin - pharmacology ; Male ; methamphetamine ; Methamphetamine - antagonists & inhibitors ; Methamphetamine - pharmacology ; Microdialysis ; Nucleus Accumbens - drug effects ; Nucleus Accumbens - metabolism ; positron emission tomography ; Rats ; Rats, Sprague-Dawley ; Sabril ; Time Factors ; Vigabatrin]]></subject><ispartof>Synapse (New York, N.Y.), 1999-10, Vol.34 (1), p.11-19</ispartof><rights>Copyright © 1999 Wiley‐Liss, Inc.</rights><rights>Copyright 1999 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4282-9348286d94f0bd2b22c7ac3a9c46c52811df7e0437b54da5d44e1e86ccd123db3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291098-2396%28199910%2934%3A1%3C11%3A%3AAID-SYN2%3E3.0.CO%3B2-5$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291098-2396%28199910%2934%3A1%3C11%3A%3AAID-SYN2%3E3.0.CO%3B2-5$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10459167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gerasimov, Madina R.</creatorcontrib><creatorcontrib>Ashby Jr, Charles R.</creatorcontrib><creatorcontrib>Gardner, Eliot L.</creatorcontrib><creatorcontrib>Mills, Mark J.</creatorcontrib><creatorcontrib>Brodie, Jonathan D.</creatorcontrib><creatorcontrib>Dewey, Stephen L.</creatorcontrib><title>Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine</title><title>Synapse (New York, N.Y.)</title><addtitle>Synapse</addtitle><description>We examined the acute effect of the irreversible GABA‐transaminase inhibitor, gamma‐vinyl GABA (GVG, Sabril®, Vigabatrin®) on increases in nucleus accumbens (NAc) dopamine (DA) following acute administration of methamphetamine, heroin, or ethanol. Methamphetamine (2.5 mg/kg) produced a dose‐dependent increase (2,700%) in NAc DA. GVG preadministration (300 or 600 mg/kg), however, inhibited this response by approximately 39 and 61%, respectively. The lower dose of methamphetamine (1.25 mg/kg), increased DA by 1,700%. This response was inhibited to a similar extent (44%) regardless of the GVG dose preadministered (300 or 600 mg/kg). In addition, heroin‐induced increases in NAc DA (0.5 mg/kg, 170%) were inhibited or completely abolished by GVG (150 or 300 mg/kg, 65 and 100%, respectively). Finally, at half the dose necessary for heroin, GVG (150 mg/kg) also completely abolished ethanol‐induced increases in NAc DA following a 0.25 g/kg challenge dose (140%). Taken with our previous findings using nicotine or cocaine as the challenge drug, these results indicate that GVG attenuates increases in NAc DA by a mechanism common to many drugs of abuse. However, it appears unlikely that an acute dose of GVG can completely inhibit increases in NAc DA following challenges with a drug whose mechanism of action is mediated primarily through the DA reuptake site. Synapse 34:11–19, 1999. © 1999 Wiley‐Liss, Inc.</description><subject>addiction</subject><subject>Analgesics, Opioid - antagonists &amp; inhibitors</subject><subject>Analgesics, Opioid - pharmacology</subject><subject>Animals</subject><subject>Anticonvulsants - pharmacology</subject><subject>Central Nervous System Depressants - antagonists &amp; inhibitors</subject><subject>Central Nervous System Depressants - pharmacology</subject><subject>dopamine</subject><subject>Dopamine - cerebrospinal fluid</subject><subject>Dopamine - metabolism</subject><subject>Dopamine Uptake Inhibitors - antagonists &amp; inhibitors</subject><subject>Dopamine Uptake Inhibitors - pharmacology</subject><subject>ethanol</subject><subject>Ethanol - antagonists &amp; inhibitors</subject><subject>Ethanol - pharmacology</subject><subject>Extracellular Space - metabolism</subject><subject>g-vinyl ^g-aminobutyric acid</subject><subject>gamma vinyl-GABA</subject><subject>gamma-Aminobutyric Acid - analogs &amp; derivatives</subject><subject>gamma-Aminobutyric Acid - pharmacology</subject><subject>heroin</subject><subject>Heroin - antagonists &amp; inhibitors</subject><subject>Heroin - pharmacology</subject><subject>Male</subject><subject>methamphetamine</subject><subject>Methamphetamine - antagonists &amp; inhibitors</subject><subject>Methamphetamine - pharmacology</subject><subject>Microdialysis</subject><subject>Nucleus Accumbens - drug effects</subject><subject>Nucleus Accumbens - metabolism</subject><subject>positron emission tomography</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Sabril</subject><subject>Time Factors</subject><subject>Vigabatrin</subject><issn>0887-4476</issn><issn>1098-2396</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV9v0zAUxS0EYmXwFVCe0CYtxdd2_rhDSCWwUmlakQoCnq4c21XN4qTEDdBvT7JMAwkEL762fO7vSOcQcg50CpSy5yfrZbE8BSrzmHGZnoCUEugpFzN4ATCbzZev4_XnK_aST-m0WJ2zOLlHJnf6-2RC8zyLhcjSI_IohC-UUg5UPCRH_ZlISLMJ8QvlvYq_ufpQRYv5q3nk6q0r3T5E3u63yu-2dq-8q-1ZtLVt4-qzqGmj4atuqtjVptPW9Eu6tSrY0N-iutOV7UKktO58aesQmWZ3w3hMHmxUFeyT23lMPly8eV-8jS9Xi2Uxv4y1YDmLJRc5y1MjxYaWhpWM6UxprqQWqU5YDmA2maWCZ2UijEqMEBZsnmptgHFT8mPybOTu2uZrZ8MevQvaVpWqbdMFTPsoec75f4WQJVT2YfbC9SjUbRNCaze4a51X7QGB4lAX4lAXDvHjED-OdSEXCAiA2NeFQ13IkWKxQoZJT316a9-V3prfmGM_v2y_u8oe_vD8t-VfHG_ePTUeqS7s7Y87qmqvsffMEvx4tcBPUAC_eLfGgv8Ej9y_Fw</recordid><startdate>199910</startdate><enddate>199910</enddate><creator>Gerasimov, Madina R.</creator><creator>Ashby Jr, Charles R.</creator><creator>Gardner, Eliot L.</creator><creator>Mills, Mark J.</creator><creator>Brodie, Jonathan D.</creator><creator>Dewey, Stephen L.</creator><general>John Wiley &amp; Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>199910</creationdate><title>Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine</title><author>Gerasimov, Madina R. ; Ashby Jr, Charles R. ; Gardner, Eliot L. ; Mills, Mark J. ; Brodie, Jonathan D. ; Dewey, Stephen L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4282-9348286d94f0bd2b22c7ac3a9c46c52811df7e0437b54da5d44e1e86ccd123db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>addiction</topic><topic>Analgesics, Opioid - antagonists &amp; inhibitors</topic><topic>Analgesics, Opioid - pharmacology</topic><topic>Animals</topic><topic>Anticonvulsants - pharmacology</topic><topic>Central Nervous System Depressants - antagonists &amp; inhibitors</topic><topic>Central Nervous System Depressants - pharmacology</topic><topic>dopamine</topic><topic>Dopamine - cerebrospinal fluid</topic><topic>Dopamine - metabolism</topic><topic>Dopamine Uptake Inhibitors - antagonists &amp; inhibitors</topic><topic>Dopamine Uptake Inhibitors - pharmacology</topic><topic>ethanol</topic><topic>Ethanol - antagonists &amp; inhibitors</topic><topic>Ethanol - pharmacology</topic><topic>Extracellular Space - metabolism</topic><topic>g-vinyl ^g-aminobutyric acid</topic><topic>gamma vinyl-GABA</topic><topic>gamma-Aminobutyric Acid - analogs &amp; derivatives</topic><topic>gamma-Aminobutyric Acid - pharmacology</topic><topic>heroin</topic><topic>Heroin - antagonists &amp; inhibitors</topic><topic>Heroin - pharmacology</topic><topic>Male</topic><topic>methamphetamine</topic><topic>Methamphetamine - antagonists &amp; inhibitors</topic><topic>Methamphetamine - pharmacology</topic><topic>Microdialysis</topic><topic>Nucleus Accumbens - drug effects</topic><topic>Nucleus Accumbens - metabolism</topic><topic>positron emission tomography</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Sabril</topic><topic>Time Factors</topic><topic>Vigabatrin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gerasimov, Madina R.</creatorcontrib><creatorcontrib>Ashby Jr, Charles R.</creatorcontrib><creatorcontrib>Gardner, Eliot L.</creatorcontrib><creatorcontrib>Mills, Mark J.</creatorcontrib><creatorcontrib>Brodie, Jonathan D.</creatorcontrib><creatorcontrib>Dewey, Stephen L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Synapse (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gerasimov, Madina R.</au><au>Ashby Jr, Charles R.</au><au>Gardner, Eliot L.</au><au>Mills, Mark J.</au><au>Brodie, Jonathan D.</au><au>Dewey, Stephen L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine</atitle><jtitle>Synapse (New York, N.Y.)</jtitle><addtitle>Synapse</addtitle><date>1999-10</date><risdate>1999</risdate><volume>34</volume><issue>1</issue><spage>11</spage><epage>19</epage><pages>11-19</pages><issn>0887-4476</issn><eissn>1098-2396</eissn><abstract>We examined the acute effect of the irreversible GABA‐transaminase inhibitor, gamma‐vinyl GABA (GVG, Sabril®, Vigabatrin®) on increases in nucleus accumbens (NAc) dopamine (DA) following acute administration of methamphetamine, heroin, or ethanol. Methamphetamine (2.5 mg/kg) produced a dose‐dependent increase (2,700%) in NAc DA. GVG preadministration (300 or 600 mg/kg), however, inhibited this response by approximately 39 and 61%, respectively. The lower dose of methamphetamine (1.25 mg/kg), increased DA by 1,700%. This response was inhibited to a similar extent (44%) regardless of the GVG dose preadministered (300 or 600 mg/kg). In addition, heroin‐induced increases in NAc DA (0.5 mg/kg, 170%) were inhibited or completely abolished by GVG (150 or 300 mg/kg, 65 and 100%, respectively). Finally, at half the dose necessary for heroin, GVG (150 mg/kg) also completely abolished ethanol‐induced increases in NAc DA following a 0.25 g/kg challenge dose (140%). Taken with our previous findings using nicotine or cocaine as the challenge drug, these results indicate that GVG attenuates increases in NAc DA by a mechanism common to many drugs of abuse. However, it appears unlikely that an acute dose of GVG can completely inhibit increases in NAc DA following challenges with a drug whose mechanism of action is mediated primarily through the DA reuptake site. Synapse 34:11–19, 1999. © 1999 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>10459167</pmid><doi>10.1002/(SICI)1098-2396(199910)34:1&lt;11::AID-SYN2&gt;3.0.CO;2-5</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0887-4476
ispartof Synapse (New York, N.Y.), 1999-10, Vol.34 (1), p.11-19
issn 0887-4476
1098-2396
language eng
recordid cdi_proquest_miscellaneous_69993833
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects addiction
Analgesics, Opioid - antagonists & inhibitors
Analgesics, Opioid - pharmacology
Animals
Anticonvulsants - pharmacology
Central Nervous System Depressants - antagonists & inhibitors
Central Nervous System Depressants - pharmacology
dopamine
Dopamine - cerebrospinal fluid
Dopamine - metabolism
Dopamine Uptake Inhibitors - antagonists & inhibitors
Dopamine Uptake Inhibitors - pharmacology
ethanol
Ethanol - antagonists & inhibitors
Ethanol - pharmacology
Extracellular Space - metabolism
g-vinyl ^g-aminobutyric acid
gamma vinyl-GABA
gamma-Aminobutyric Acid - analogs & derivatives
gamma-Aminobutyric Acid - pharmacology
heroin
Heroin - antagonists & inhibitors
Heroin - pharmacology
Male
methamphetamine
Methamphetamine - antagonists & inhibitors
Methamphetamine - pharmacology
Microdialysis
Nucleus Accumbens - drug effects
Nucleus Accumbens - metabolism
positron emission tomography
Rats
Rats, Sprague-Dawley
Sabril
Time Factors
Vigabatrin
title Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T03%3A40%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gamma-vinyl%20GABA%20inhibits%20methamphetamine,%20heroin,%20or%20ethanol-induced%20increases%20in%20nucleus%20accumbens%20dopamine&rft.jtitle=Synapse%20(New%20York,%20N.Y.)&rft.au=Gerasimov,%20Madina%20R.&rft.date=1999-10&rft.volume=34&rft.issue=1&rft.spage=11&rft.epage=19&rft.pages=11-19&rft.issn=0887-4476&rft.eissn=1098-2396&rft_id=info:doi/10.1002/(SICI)1098-2396(199910)34:1%3C11::AID-SYN2%3E3.0.CO;2-5&rft_dat=%3Cproquest_cross%3E17509396%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17509396&rft_id=info:pmid/10459167&rfr_iscdi=true